Netanyahu Tries to Leave Graft Charges Behind in Visit to Trump
(Bloomberg) -- Israeli Prime Minister Benjamin Netanyahu's visit to the Trump White House on Monday will give him an opportunity to divert attention from a widening corruption probe to a stage where he can showcase achievements.
But while he's sure to trumpet successes such as winning U.S. recognition of Jerusalem as Israel's capital, behind the scenes he'll be struggling to muster U.S. support on a much more urgent issue: keeping Iran and its proxies in check across the northern border with Syria.
Netanyahu, who landed in Washington early Sunday, wants to see “the concrete terms of what they're going to do to make sure that Iran doesn't transform Syria into a forward base against Israel,” said Michael Oren, deputy minister for public diplomacy and a former ambassador to Washington. He'll be looking for “something more than a statement,” he said.
As seven years of Syrian fighting approach a probable conclusion, Iran is trying to consolidate gains it achieved as Syrian President Bashar al-Assad's chief on-the-ground ally. Israel, which considers Iran its top foe, doesn't want Tehran to establish a permanent military presence near the Israeli-held Golan Heights, and has been disappointed by Washington's failure to block it. Without support from the U.S. or Russia, whose air force has turned the war's tide in Assad's favor, Israeli leaders will be left with a tough choice: Tolerate Iran on their doorstep, or risk going to war to prevent it.
Nuclear Deal
Netanyahu will also seek to coordinate strategy to press to revise the 2015 nuclear deal between world powers and Iran, Oren said. Israel backed Trump's threat to pull out of the accord in May unless European parties to it agree to new limits on Iran's nuclear activities and ballistic missile program.
Before he left Israel, Netanyahu said his first priority in talks with Trump was to discuss Iran's “aggression, its nuclear aspirations, and its aggressive actions in the Middle East in general and on our borders.” Iran says its nuclear program is peaceful.
Netanyahu visits the White House at one of the most difficult points in his political career, with Israel's attorney general weighing whether to act on police recommendations to put him on trial for corruption. He says he's the innocent victim of a witch hunt, sharing common ground with Trump, who has often used that term to denounce the expanding inquiry into his presidential campaign's ties to Russia as a sham.
“They both are under investigation and they both have shown contempt for the investigators,” said Yoram Meital, director of the Chaim Herzog Center for Middle East Studies and Diplomacy at Israel's Ben-Gurion University of the Negev. “It's a bonding thing.”
Fifth Meeting
Netanyahu, whose meeting with the president this week will be the fifth since Trump took office, can usually depend on lavish praise from the U.S. leader after eight years of friction with former President Barack Obama. Moving the U.S. embassy from Tel Aviv is a break from 70 years of U.S. foreign policy that has delighted their Jewish and evangelical Christian supporters.
“This is a victory lap for both of them,” said David Makovsky, a former member of the Obama's Mideast negotiating team.
Israeli leaders believe Trump won't backpedal on his commitment to scrap the deal unless it gets rewritten, Oren said separately in a conference call with reporters. “If the Europeans try to get away with a minimal fix, it certainly won't suffice for Israel,” Oren said.
As Netanyahu's legal entanglements mounted in recent weeks, Israel-Palestinian peace efforts became a stage for a rare sign of public friction between the two leaders. Trump told an Israeli newspaper that he is “not necessarily sure that Israel is looking to make peace,” and the White House denied Netanyahu's reported claim that he had discussed annexing part of the West Bank with the U.S. administration.
Netanyahu's legal woes and the political toll they've taken may allow Trump to smell weakness -- to twist the prime minister's arm in an effort to win concessions that could bring the Palestinians back to the negotiating table. “He and members of his administration have said frequently that there are going to be parts of this plan that are difficult for Israel,” Oren said.
‘Dead on Arrival'
Trump's Middle East peace plan may be put on hold, however, in part because of Palestinian opposition to his Jerusalem declaration. The Palestinians seek the eastern sector of the city for the capital of a future state, and have stopped talking to the White House over the move.
“It's dead on arrival for sure,” said Zaha Hassan, a fellow at the New America think tank in Washington and former legal adviser to the Palestinian negotiating team. While details have not been revealed, Hassan says it's evident the Trump blueprint won't enable Palestinians to establish a full-fledged independent state. “It would be more of a souped-up version of the status quo,” she said.
The peace plan may also run into turbulence over the downgrading of lead negotiator Jared Kushner's security clearance. One reason for the downgrade was that officials in Israel and at least three other countries privately discussed ways to manipulate Kushner, a foreign policy neophyte who is Trump's son-in-law, the Washington Post reported.
--With assistance from Roxana Tiron
To contact the reporter on this story: Jonathan Ferziger in Tel Aviv at jferziger@bloomberg.net.
To contact the editors responsible for this story: Alaa Shahine at asalha@bloomberg.net, Steve Geimann, Ros Krasny
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.